Answers are grounded in this paper and cite their sources.
Laboratory preparedness with quality-assured diagnostic assays is essential for controlling the current coronavirus disease (COVID-19) outbreak. We conducted an external quality assessment study with inactivated severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) samples to support clinical laboratories with a proficiency testing option for molecular assays. To analyse SARS-CoV-2 testing performance, we used an online questionnaire developed for the European Union project RECOVER to assess molecular testing capacities in clinical diagnostic laboratories.
No takes yet. Share an insight, caveat, or question.
Matheeussen et al. (2020) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: